Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/04/2012 | US20120252743 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
10/04/2012 | US20120252742 Human Single-Chain T Cell Receptors |
10/04/2012 | US20120252741 Novel semi-synthetic glycopeptides as antibacterial agents |
10/04/2012 | US20120252740 Hdac inhibitors and therapeutic methods of using same |
10/04/2012 | US20120252739 Tubulin Inhibitors |
10/04/2012 | US20120252738 Tubulin Inhibitors |
10/04/2012 | US20120252737 Methods for Diagnosing and Treating Cancer |
10/04/2012 | US20120252736 Methods involving pdgfrbeta inhibitors |
10/04/2012 | US20120252735 Treatment of skin conditions by dickkopf1 (dkk1) |
10/04/2012 | US20120252734 Inhibitors of antigen presentation by mhc class ii molecules |
10/04/2012 | US20120252733 Use of targeted nitroxide agents in bone healing |
10/04/2012 | US20120252732 Albumin fusion proteins |
10/04/2012 | US20120252731 Co-Administration of An Agent Linked to an Internalization Peptide With an Anti-Inflammatory |
10/04/2012 | US20120252730 Platelet aggregation inhibitors |
10/04/2012 | US20120252729 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units |
10/04/2012 | US20120252728 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome |
10/04/2012 | US20120252727 Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids |
10/04/2012 | US20120252726 Novel neurotrophic factors |
10/04/2012 | US20120252725 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
10/04/2012 | US20120252724 Insulin preparations containing methionine |
10/04/2012 | US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis |
10/04/2012 | US20120252722 Metal-binding therapeutic peptides |
10/04/2012 | US20120252721 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
10/04/2012 | US20120252720 Compositions for treatment of ear disorders and methods of use thereof |
10/04/2012 | US20120252719 Water soluble membrane proteins and methods for the preparation and use thereof |
10/04/2012 | US20120252718 Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA |
10/04/2012 | US20120252717 Conjugates of biologically active proteins having a modified in vivo half-life |
10/04/2012 | US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins |
10/04/2012 | US20120251633 Amino Acid Composition With Improved Dispersibility |
10/04/2012 | US20120251629 Methods of treatment and screening assays for hif-1alpha regulation |
10/04/2012 | US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
10/04/2012 | US20120251614 Processed feeds, foods and biofuels and methods of making and using them |
10/04/2012 | US20120251613 Method for treating vitiligo with a prostaglandin analogue |
10/04/2012 | US20120251611 Super-hydrophilic structures |
10/04/2012 | US20120251596 Nanoemulsion, method for its preparation and use |
10/04/2012 | US20120251594 Delivery of Submicrometer and Nanometer Aerosols to the Lungs Using Hygroscopic Excipients or Dual Stream Nasal Delivery |
10/04/2012 | US20120251591 Polymer carrier |
10/04/2012 | US20120251586 Ligand-specific inhibition of attachment of immune cells to implantable biomaterials |
10/04/2012 | US20120251581 Novel Compound and Methods for its Production |
10/04/2012 | US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides |
10/04/2012 | US20120251562 Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity |
10/04/2012 | US20120251560 Conjugated lipomers and uses thereof |
10/04/2012 | US20120251545 Therapeutic Combinations Of Hydroxybenzamide Derivatives As Inhibitors Of HSP90 |
10/04/2012 | US20120251543 Methods and compositions for modulating apoptosis |
10/04/2012 | US20120251538 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2 |
10/04/2012 | US20120251536 Biopolymer hybrid gel-depot delivery system |
10/04/2012 | US20120251535 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
10/04/2012 | US20120251534 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
10/04/2012 | US20120251523 Methods of Modulating TGFbeta Signaling |
10/04/2012 | US20120251522 Targeted delivery of therapeutic agents with lyophilized matrices |
10/04/2012 | US20120251520 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
10/04/2012 | US20120251519 Endopeptidase Treatment of Smooth Muscle Disorders |
10/04/2012 | US20120251518 Endopeptidase Treatment of Sexual Dysfunction Disorders |
10/04/2012 | US20120251517 Super fast-acting insulin compositions |
10/04/2012 | US20120251516 Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent |
10/04/2012 | US20120251510 Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood |
10/04/2012 | US20120251503 Methods of using chimeric coiled-coil molecule |
10/04/2012 | US20120251502 Human Ebola Virus Species and Compositions and Methods Thereof |
10/04/2012 | US20120251499 Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single cpg site in ttp promoter and treatment of cancers by regulating its epigenetic status |
10/04/2012 | US20120251497 Inhibitors of hepatitis c virus |
10/04/2012 | US20120251496 Ezatiostat for treating multiple myeloma |
10/04/2012 | US20120251495 Pterin based therapies for inflammatory conditions |
10/04/2012 | US20120251494 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
10/04/2012 | US20120251493 Novel macrocyclic inhibitors of hepatitis c virus replication |
10/04/2012 | US20120251492 Triterpene derivative and agent for preventing or treating chronic hepatitis c |
10/04/2012 | US20120251491 Fused tricyclic aryl compounds useful for the treatment of viral diseases |
10/04/2012 | US20120251490 Compositions And Methods For Immunotherapy |
10/04/2012 | US20120251489 Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
10/04/2012 | US20120251488 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
10/04/2012 | US20120251487 Compounds and pharmaceutical compositions for the treatment of viral infections |
10/04/2012 | US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
10/04/2012 | US20120251485 Antibody targeting osteoclast-related protein siglec-15 |
10/04/2012 | US20120251483 Infarction Treatment Compositions and Methods |
10/04/2012 | US20120251482 Use for improving 5-ht function and enos expression of kmups amine salts |
10/04/2012 | US20120251457 Methods and compositions for modulating adipocyte function |
10/04/2012 | US20120251453 Methods and Compositions Related to Annexin 1-Binding Compounds |
10/04/2012 | US20120251444 Treatment of liver disorders by administration of rap conjugates |
10/04/2012 | US20120251441 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments |
10/04/2012 | US20120251439 Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis |
10/04/2012 | DE102011001768A1 Präparat oder Nahrungsergänzungsmittel Preparation, or dietary supplement |
10/04/2012 | CA2837122A1 Methods and compositions for enhancing the uptake of therapeutic agents by target cells |
10/04/2012 | CA2832151A1 Methods and compositions for treating brain diseases |
10/04/2012 | CA2832041A1 Aureobasidin derivatives and methods of synthesis |
10/04/2012 | CA2831938A1 Methods and uses of semaphorin 3e polypeptides and polynucleotides involving an airway inflammatory disease |
10/04/2012 | CA2831908A1 Lyophilized preparation of botulinum toxin |
10/04/2012 | CA2831675A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases |
10/04/2012 | CA2831667A1 Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life |
10/04/2012 | CA2831429A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |
10/04/2012 | CA2831427A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan |
10/04/2012 | CA2830974A1 Novel glucagon analogues |
10/04/2012 | CA2830948A1 Osmotic mediated release synthetic nanocarriers |
10/04/2012 | CA2830811A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
10/04/2012 | CA2830375A1 Methods and compositions for targeting adipose cells in mammals |
10/04/2012 | CA2830135A1 Method for treating disorders of the skin |
10/04/2012 | CA2830112A1 Selection of hcv treatment |
10/04/2012 | CA2829241A1 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
10/04/2012 | CA2829130A1 Ezatiostat for treating multiple myeloma |
10/04/2012 | CA2829122A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor |
10/03/2012 | EP2506008A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby |
10/03/2012 | EP2505593A1 Compositions comprising an acylated insulin and zinc and method of making the said compositions |